Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
A Major Leap Forward in Viral Clearance Technology
Stephanie McGary, Janice A. Lonardo
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 82
 

A Comprehensive Solution



Innovative Viresolve Pro Family: Robust, productive, next generation

Quality and Manufacturing Expertise: Over 15 years of virus filter manufacturing experience; state-of-the-art membrane plant; comprehensive validation; raising the standard of performance and integrity tests

Industry-Leading Service and Support: Process development, optimization, and scale-up; leading the industry with spiking strategy and validation; services covering every stage of adoption

Building Assurance Test By Test (Figure 1)

No one does more than Millipore to help assure virus filter performance and compliance: end-user validation and testing; device 100% tests (newly patented binary gas test); device release tests; membrane release tests; and process and product validation.



Key Benefits (Figure 2)

Process Robustness: Enables increased process robustness; protects against variability with respect to changes in solution conditions; relatively insensitive to stream plugging characteristics; limits the optimization required (superior template fit)



Productivity: Enables high productivity, enhancing Viresolve Pro performance; increased mass capacities coupled with high protein flux; easy to install, test, and use; caustic stable; disposable flow path at all scales

Author Details
Stephanie McGary and Janice A. Lonardo are product managers at Millipore Corporation, 290 Concord Road, Billerica, MA 01821; 1-800-645-5476; www.millipore.com.

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550